PortfoliosLab logoPortfoliosLab logo
AQX.L vs. RGEN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AQX.L vs. RGEN - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Aquis Exchange plc (AQX.L) and Repligen Corporation (RGEN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

AQX.L is traded in GBp, while RGEN is traded in USD. To make them comparable, the RGEN values have been converted to GBp using the latest available exchange rates.

Returns By Period


AQX.L

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

RGEN

1D
0.76%
1M
3.81%
YTD
-25.44%
6M
-27.28%
1Y
-1.46%
3Y*
-12.28%
5Y*
-6.30%
10Y*
18.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AQX.L vs. RGEN - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
AQX.L
Aquis Exchange plc
0.00%-100.00%91.10%-3.95%-39.68%34.04%16.92%-29.78%54.73%
RGEN
Repligen Corporation
-25.44%5.73%-18.55%0.89%-28.47%39.51%101.08%68.72%22.44%

Correlation

The correlation between AQX.L and RGEN is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2018

0.07

Fundamentals

Total Revenue (TTM)

AQX.L:

£47.48M

RGEN:

$763.34M

Gross Profit (TTM)

AQX.L:

£15.81M

RGEN:

$285.10M

EBITDA (TTM)

AQX.L:

£8.52M

RGEN:

$156.19M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AQX.L vs. RGEN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AQX.L

RGEN
RGEN Risk / Return Rank: 3737
Overall Rank
RGEN Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
RGEN Sortino Ratio Rank: 3636
Sortino Ratio Rank
RGEN Omega Ratio Rank: 3535
Omega Ratio Rank
RGEN Calmar Ratio Rank: 3838
Calmar Ratio Rank
RGEN Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AQX.L vs. RGEN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aquis Exchange plc (AQX.L) and Repligen Corporation (RGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

AQX.L vs. RGEN - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


AQX.LRGENDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.13

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

0.47

Drawdowns

AQX.L vs. RGEN - Drawdown Comparison


Loading charts...

Drawdown Indicators


AQX.LRGENDifference

Max Drawdown

Largest peak-to-trough decline

-67.37%

Max Drawdown (1Y)

Largest decline over 1 year

-40.88%

Max Drawdown (3Y)

Largest decline over 3 years

-53.37%

Max Drawdown (5Y)

Largest decline over 5 years

-67.37%

Max Drawdown (10Y)

Largest decline over 10 years

-67.37%

Current Drawdown

Current decline from peak

-61.64%

Average Drawdown

Average peak-to-trough decline

-23.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.78%

Volatility

AQX.L vs. RGEN - Volatility Comparison


Loading charts...

Volatility by Period


AQX.LRGENDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.67%

Volatility (6M)

Calculated over the trailing 6-month period

29.35%

Volatility (1Y)

Calculated over the trailing 1-year period

43.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

49.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.40%

Dividends

AQX.L vs. RGEN - Dividend Comparison

Neither AQX.L nor RGEN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AQX.L vs. RGEN - Financials Comparison

This section allows you to compare key financial metrics between Aquis Exchange plc and Repligen Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M202120222023202420252026
14.25M
194.26M
(AQX.L) Total Revenue
(RGEN) Total Revenue
Please note, different currencies. AQX.L values in GBp, RGEN values in USD

Frequently Asked Questions


AQX.L and RGEN have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for AQX.L and RGEN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer